The Use of 2.5% Natamycin,as Orally Administered Drops,in the Treatment of Fungal Infections of the Oral Cavity in Children with Chronic Blood Diseases
Restricted accessResearch articleFirst published online January, 1989
The Use of 2.5% Natamycin,as Orally Administered Drops,in the Treatment of Fungal Infections of the Oral Cavity in Children with Chronic Blood Diseases
A total of 34 children with oral candidiasis were treated with 2.5% natamycin in the form of orally administered drops; 6–20 drops applied to oral lesions four times daily for up to 8 weeks. A total cure was achieved in 28 (82.3%) cases. No side-effects were observed. This preparation was an effective treatment for Candida albicans infections in children with blood diseases, and was well tolerated.
SchöpfE: Side effects from topical corticosteroids therapy. Review article. Ann Clin Res1975; 7: 353–355.
2.
SmosarskaHRudowska-SkoczylasE: Pimafucin in treatment of oral candidiasis. Czasop Stomatol1977; 30: 773–775.
3.
KurnatowskaAKwasniewskaJ: The efficacy of different forms of natamycin in treatment of mucous membrane and skin candidosis. Przegl Dermatol1981; 68: 101–104.
4.
PorebskaALaskowickaZZemburowaK: Fungostatic in vitro activity of a new antibiotic. Med Dosw Mikrobiol1971; 23: 71–76.
AnsergRBickenbachRMiehlmannJ: Differenzierung hefeahnlicker Pilze aus klinischen Untersuchungematerial mit dem API 20C system. Arztl Lab1976; 22: 243–248.
7.
HoistE: Natamycin and nystatin for treatment of oral candidosis during and after radiotherapy. J Prosthet Dent1984; 51: 226–231.
8.
KoopmansASFSilleuis SmittPAEKalkW: Efficacy of 2.5 % pimafucin suspension in the treatment of denture stomatitis. J Prosthet Dent1984; 51: 461–466.
9.
LaskownickaZPasykKPorebskaA: Pimafucin/natamycin in the treatment of superficial fungal infections in children. Acta Paediatr Scand1971; 60: 456–460.
10.
MoscaMNespoliLDi SilverioA: Natamycin suspension in the treatment of superficial mycosis. Ann Dermatol Clin Sper1984; 38: 185–192.
11.
NespoliL: Prophylaxis and treatment of oral candidosis with natafucin 2.5% drops in children affected by acute lymphatic leukemia. Pediatr Oggi1984; 4: 346–348.
12.
SpiechowiczEBakZBielunskaS: Clinical evaluation of natamycin 2.5% suspension in the treatment of a denture stomatitis. Castellania1977; 5: 175–180.
13.
SyrynskaMStelmachowska-DworakS: Pimafucin in the treatment of certain oral mucosa diseases complicated with candidiasis. Czasop Stomatol1982; 35: 725–729.
